Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Cole

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|September 5, 2007
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemiaPeter D Cole, Richard A Drachtman, Margaret Masterson, et al.
British Journal of Haematology|June 11, 2019
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology GroupKara M Kelly, Peter D Cole, Qinglin Pei, et al.
Pediatric Blood & Cancer|December 14, 2016
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemiaYaron Finkelstein, Traci M Blonquist, Veena Vijayanathan, et al.
Genes & Nutrition|December 16, 2014
γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cellsSung-Eun Kim, Toshinori Hinoue, Michael S Kim, et al.
Journal of Neurochemistry|December 19, 2007
Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture modelJan B Wollack, Benedette Makori, Stuti Ahlawat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic LeukemiaPeter D Cole, Yaron Finkelstein, Kristen E Stevenson, et al.
Pediatric Blood & Cancer|March 26, 2022
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology GroupIlia N Buhtoiarov, Nkechi I Mba, Crystal D L Santos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2023
Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemiaPeter D Cole, Soo Young Kim, Yuelin Li, et al.
Frontiers in Molecular Neuroscience|December 14, 2023
The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive functionMohammad Abdur Rashid, Jason J Tang, Ki-Hyun Yoo, et al.
Journal of Pediatric Hematology/Oncology Nursing|October 12, 2022
Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia ConsortiumJustine M Kahn, Kristen Stevenson, Melissa Beauchemin, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|September 5, 2007
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemiaPeter D Cole, Richard A Drachtman, Margaret Masterson, et al.
British Journal of Haematology|June 11, 2019
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology GroupKara M Kelly, Peter D Cole, Qinglin Pei, et al.
Pediatric Blood & Cancer|December 14, 2016
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemiaYaron Finkelstein, Traci M Blonquist, Veena Vijayanathan, et al.
Genes & Nutrition|December 16, 2014
γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cellsSung-Eun Kim, Toshinori Hinoue, Michael S Kim, et al.
Journal of Neurochemistry|December 19, 2007
Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture modelJan B Wollack, Benedette Makori, Stuti Ahlawat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic LeukemiaPeter D Cole, Yaron Finkelstein, Kristen E Stevenson, et al.
Pediatric Blood & Cancer|March 26, 2022
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology GroupIlia N Buhtoiarov, Nkechi I Mba, Crystal D L Santos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2023
Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemiaPeter D Cole, Soo Young Kim, Yuelin Li, et al.
Frontiers in Molecular Neuroscience|December 14, 2023
The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive functionMohammad Abdur Rashid, Jason J Tang, Ki-Hyun Yoo, et al.
Journal of Pediatric Hematology/Oncology Nursing|October 12, 2022
Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia ConsortiumJustine M Kahn, Kristen Stevenson, Melissa Beauchemin, et al.
Pageof 11